Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1053 U.S. listed China Stocks and Counting...
 Tracking 1535 U.S. Stocks and Counting...

 Skystar Bio-Pharma (NASDAQ:SKBI)

Friday, April 15, 2011

"In 2010, Skystar continued to utilize working capital to prepay for raw materials. This buy-forward strategy helped Skystar manage fluctuations in raw material costs. Skystar as of current has adequate working capital to fund its operations and prepayment of raw materials but will continue to seek ways to improve its working capital position.


Tuesday, November 16, 2010

We have sufficient capital to support our ongoing operations. However, if we are to acquire another business or further expand our operations, we may need additional capital.